Rodger Novak
2015
In 2015, Rodger Novak earned a total compensation of $1.7M as Chief Executive Officer at CRISPR Therapeutics AG.
Compensation breakdown
| Non-Equity Incentive Plan | $118,424 |
|---|---|
| Option Awards | $820,587 |
| Salary | $356,242 |
| Stock Awards | $326,360 |
| Other | $66,968 |
| Total | $1,688,581 |
Novak received $820.6K in option awards, accounting for 49% of the total pay in 2015.
Novak also received $118.4K in non-equity incentive plan, $356.2K in salary, $326.4K in stock awards and $67K in other compensation.
Rankings
In 2015, Rodger Novak's compensation ranked 5,440th out of 13,638 executives tracked by ExecPay. In other words, Novak earned more than 60.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,440 out of 13,638 | 60th |
Division Manufacturing | 2,015 out of 5,190 | 61st |
Major group Chemicals And Allied Products | 732 out of 1,854 | 61st |
Industry group Drugs | 581 out of 1,528 | 62nd |
Industry Biological Products, Except Diagnostic Substances | 100 out of 254 | 61st |
Source: SEC filing on April 18, 2017.